Fundz

Euphrates Vascular, Inc. reported raising $590,000 in an initial SEC Form D filing, from an offering of $4 Million

PRIVATESep 17, 2018$590K of $4M raised

Amount Raised

$590,000

$590,000 sold, per SEC Form D (first sale Sep 17, 2018)

Round Type

Seed

St. LouisBiotechnology

Quick answer

Euphrates Vascular, Inc. raised $590,000 in a Seed round, dated September 17, 2018. Euphrates Vascular, Inc. is based in St. Louis, Missouri, United States.

How much did Euphrates Vascular, Inc. raise?
Euphrates Vascular, Inc. raised $590,000 in a Seed round on September 17, 2018.
What does Euphrates Vascular, Inc. do?
Euphrates Vascular uses nanotechnology and magnetic fields to treat vascular occlusions beyond the reach of traditional wire and catheters
Where is Euphrates Vascular, Inc. based and how big is it?
Euphrates Vascular, Inc. is based in St. Louis, Missouri, United States.
Who are the decision-makers at Euphrates Vascular, Inc?
Fundz holds 1 contact at Euphrates Vascular, Inc., including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Euphrates Vascular, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • 1Long raised $266K (Pre-Seed) on October 31, 2018.
  • Emergent Biosolutions raised $48M on October 30, 2018.
  • Rockwell Medical raised $22M on October 30, 2018.
  • Clear Labs raised $19M on October 30, 2018.
  • Bactana raised $1.3M (Seed) on October 30, 2018.
  • pHLIP, Inc. raised $4.4M (Seed) on October 30, 2018.

Who to call at Euphrates Vascular, Inc., and when

A new round usually means Euphrates Vascular, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Euphrates Vascular, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Euphrates Vascular, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Euphrates Vascular, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Euphrates Vascular, Inc.

Location

8460 Watson Road

St. Louis, Missouri, United States

About

Euphrates Vascular uses nanotechnology and magnetic fields to treat vascular occlusions beyond the reach of traditional wire and catheters

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Euphrates Vascular, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsCatherine M., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Euphrates Vascular, Inc.'s next move

See what Strategic adds

Euphrates Vascular, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.